Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 15 | 2020 | 185 | 3.540 |
Why?
|
| Kidney Transplantation | 11 | 2020 | 515 | 2.360 |
Why?
|
| Tissue Donors | 8 | 2017 | 208 | 2.030 |
Why?
|
| Kidney Failure, Chronic | 5 | 2017 | 548 | 0.910 |
Why?
|
| Tissue and Organ Procurement | 5 | 2017 | 99 | 0.800 |
Why?
|
| Donor Selection | 3 | 2020 | 36 | 0.800 |
Why?
|
| Graft Survival | 5 | 2019 | 315 | 0.740 |
Why?
|
| Postoperative Complications | 6 | 2020 | 849 | 0.710 |
Why?
|
| Renal Insufficiency | 2 | 2020 | 58 | 0.690 |
Why?
|
| Liver Failure | 1 | 2020 | 22 | 0.620 |
Why?
|
| Waiting Lists | 3 | 2017 | 36 | 0.570 |
Why?
|
| Brain Death | 3 | 2012 | 27 | 0.530 |
Why?
|
| Poverty | 1 | 2018 | 118 | 0.510 |
Why?
|
| Bile Duct Diseases | 3 | 2011 | 10 | 0.470 |
Why?
|
| Registries | 3 | 2017 | 328 | 0.440 |
Why?
|
| Death | 2 | 2012 | 53 | 0.440 |
Why?
|
| Liver Diseases | 2 | 2013 | 75 | 0.430 |
Why?
|
| Living Donors | 4 | 2020 | 64 | 0.420 |
Why?
|
| Comparative Effectiveness Research | 2 | 2014 | 29 | 0.410 |
Why?
|
| Retrospective Studies | 10 | 2020 | 3812 | 0.410 |
Why?
|
| Middle Aged | 13 | 2020 | 12703 | 0.350 |
Why?
|
| Renal Dialysis | 4 | 2017 | 282 | 0.340 |
Why?
|
| Models, Statistical | 1 | 2012 | 193 | 0.340 |
Why?
|
| Humans | 24 | 2020 | 34474 | 0.330 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2011 | 73 | 0.320 |
Why?
|
| United States | 7 | 2017 | 4267 | 0.310 |
Why?
|
| Heart Arrest | 1 | 2010 | 43 | 0.310 |
Why?
|
| Risk Factors | 7 | 2017 | 4136 | 0.290 |
Why?
|
| Adult | 12 | 2020 | 10015 | 0.290 |
Why?
|
| Health Care Costs | 1 | 2010 | 126 | 0.290 |
Why?
|
| Male | 15 | 2020 | 20697 | 0.280 |
Why?
|
| Quality of Life | 2 | 2016 | 1032 | 0.280 |
Why?
|
| Female | 13 | 2020 | 21490 | 0.250 |
Why?
|
| Proportional Hazards Models | 3 | 2017 | 803 | 0.240 |
Why?
|
| Time Factors | 4 | 2020 | 2352 | 0.230 |
Why?
|
| Treatment Outcome | 7 | 2017 | 3618 | 0.200 |
Why?
|
| Aged | 6 | 2020 | 10998 | 0.190 |
Why?
|
| Risk Assessment | 4 | 2017 | 1506 | 0.180 |
Why?
|
| Cost-Benefit Analysis | 2 | 2013 | 197 | 0.180 |
Why?
|
| Transplantation, Homologous | 2 | 2020 | 163 | 0.160 |
Why?
|
| Age Factors | 3 | 2019 | 1261 | 0.150 |
Why?
|
| Ischemia | 2 | 2011 | 119 | 0.150 |
Why?
|
| Genetic Testing | 1 | 2020 | 99 | 0.150 |
Why?
|
| Survival Analysis | 4 | 2019 | 509 | 0.150 |
Why?
|
| Markov Chains | 3 | 2015 | 32 | 0.150 |
Why?
|
| Survival Rate | 1 | 2020 | 925 | 0.130 |
Why?
|
| Computer Simulation | 2 | 2015 | 250 | 0.130 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2017 | 35 | 0.130 |
Why?
|
| Nephrology | 1 | 2017 | 33 | 0.130 |
Why?
|
| Quality Indicators, Health Care | 1 | 2017 | 63 | 0.130 |
Why?
|
| Kidney Function Tests | 1 | 2017 | 107 | 0.130 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2020 | 302 | 0.120 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 304 | 0.120 |
Why?
|
| Continental Population Groups | 1 | 2018 | 245 | 0.120 |
Why?
|
| Glomerular Filtration Rate | 1 | 2017 | 315 | 0.120 |
Why?
|
| Tissue and Organ Harvesting | 2 | 2020 | 37 | 0.120 |
Why?
|
| Minority Groups | 1 | 2016 | 90 | 0.120 |
Why?
|
| Healthcare Disparities | 1 | 2018 | 183 | 0.110 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 703 | 0.110 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 2366 | 0.110 |
Why?
|
| Ethnic Groups | 1 | 2018 | 483 | 0.110 |
Why?
|
| Policy Making | 1 | 2015 | 20 | 0.110 |
Why?
|
| Diabetes Complications | 1 | 2016 | 189 | 0.110 |
Why?
|
| Medicare | 1 | 2016 | 217 | 0.110 |
Why?
|
| Prognosis | 2 | 2017 | 1603 | 0.110 |
Why?
|
| Models, Theoretical | 1 | 2015 | 145 | 0.100 |
Why?
|
| Health Resources | 2 | 2010 | 35 | 0.100 |
Why?
|
| Coronary Artery Disease | 1 | 2016 | 441 | 0.100 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2013 | 35 | 0.100 |
Why?
|
| Young Adult | 2 | 2019 | 2825 | 0.100 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 260 | 0.090 |
Why?
|
| Myocardial Infarction | 1 | 2016 | 515 | 0.090 |
Why?
|
| Decision Trees | 1 | 2012 | 31 | 0.090 |
Why?
|
| Kidney Diseases | 1 | 2014 | 249 | 0.090 |
Why?
|
| Informed Consent | 1 | 2011 | 45 | 0.090 |
Why?
|
| Primary Graft Dysfunction | 1 | 2011 | 1 | 0.090 |
Why?
|
| Biliary Tract Diseases | 1 | 2011 | 12 | 0.080 |
Why?
|
| Renal Veins | 1 | 2010 | 7 | 0.080 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2010 | 13 | 0.080 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2011 | 66 | 0.080 |
Why?
|
| Hepatitis C, Chronic | 1 | 2011 | 77 | 0.080 |
Why?
|
| Patient Selection | 1 | 2012 | 291 | 0.080 |
Why?
|
| Age Distribution | 1 | 2011 | 211 | 0.080 |
Why?
|
| Cause of Death | 1 | 2011 | 245 | 0.080 |
Why?
|
| Hospital Costs | 1 | 2010 | 51 | 0.080 |
Why?
|
| Reoperation | 1 | 2011 | 265 | 0.080 |
Why?
|
| Heart Failure | 1 | 2016 | 780 | 0.080 |
Why?
|
| Graft Rejection | 1 | 2011 | 242 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 2011 | 164 | 0.080 |
Why?
|
| Hepatectomy | 1 | 2009 | 57 | 0.080 |
Why?
|
| Health Status Indicators | 1 | 2009 | 75 | 0.070 |
Why?
|
| Psychometrics | 1 | 2009 | 143 | 0.070 |
Why?
|
| Laparoscopy | 1 | 2009 | 194 | 0.070 |
Why?
|
| Liver | 1 | 2010 | 510 | 0.070 |
Why?
|
| Portoenterostomy, Hepatic | 1 | 2006 | 1 | 0.060 |
Why?
|
| Biliary Atresia | 1 | 2006 | 3 | 0.060 |
Why?
|
| Ileus | 1 | 2005 | 5 | 0.060 |
Why?
|
| Pneumothorax | 1 | 2005 | 8 | 0.060 |
Why?
|
| Neuroblastoma | 1 | 2006 | 32 | 0.060 |
Why?
|
| Intestinal Diseases | 1 | 2005 | 17 | 0.060 |
Why?
|
| Cystic Fibrosis | 1 | 2005 | 25 | 0.060 |
Why?
|
| Peptides | 1 | 2006 | 142 | 0.060 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2006 | 123 | 0.050 |
Why?
|
| Infant | 3 | 2019 | 1122 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2019 | 1354 | 0.040 |
Why?
|
| Nephrectomy | 1 | 2020 | 127 | 0.040 |
Why?
|
| African Continental Ancestry Group | 1 | 2020 | 367 | 0.040 |
Why?
|
| Child | 2 | 2019 | 2613 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 429 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 849 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2017 | 190 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2017 | 130 | 0.030 |
Why?
|
| Coronary Angiography | 1 | 2016 | 168 | 0.030 |
Why?
|
| Adolescent | 2 | 2019 | 3799 | 0.030 |
Why?
|
| Comorbidity | 1 | 2016 | 596 | 0.030 |
Why?
|
| Logistic Models | 1 | 2016 | 808 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2006 | 730 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 819 | 0.020 |
Why?
|
| Empirical Research | 1 | 2011 | 9 | 0.020 |
Why?
|
| Liver Circulation | 1 | 2010 | 7 | 0.020 |
Why?
|
| Mesenteric Veins | 1 | 2010 | 10 | 0.020 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2010 | 7 | 0.020 |
Why?
|
| Iliac Vein | 1 | 2010 | 8 | 0.020 |
Why?
|
| Portal Vein | 1 | 2010 | 27 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2010 | 95 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2010 | 31 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2011 | 261 | 0.020 |
Why?
|
| Liver Regeneration | 1 | 2009 | 25 | 0.020 |
Why?
|
| Decision Making | 1 | 2011 | 203 | 0.020 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2009 | 30 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2009 | 953 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2006 | 11 | 0.010 |
Why?
|
| Meconium | 1 | 2005 | 2 | 0.010 |
Why?
|
| Intussusception | 1 | 2005 | 2 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2006 | 180 | 0.010 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2005 | 17 | 0.010 |
Why?
|
| Abdomen | 1 | 2005 | 52 | 0.010 |
Why?
|
| Proteomics | 1 | 2006 | 106 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 2006 | 265 | 0.010 |
Why?
|